Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Angiography-Derived Physiological Indices in Patients Undergoing OCT-Guided Percutaneous Coronary Intervention

NCT07511231 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07511231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Angiography-Derived Physiological Indices in Patients Undergoing OCT-Guided Percutaneous Coronary Intervention
Lead sponsor
Beijing Anzhen Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
July 31, 2029
Enrollment
1,800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ashd))